Search

research lab at UT Southwestern for Yun "Claudia" Wei, Ph.D.

Skip to main content News August 19 2026 AHA Scientific Sessions 2026 Abstract Accepted: Targeted mTOR Suppression with Optoacoustic Imaging for Myocardial Ischemia/Reperfusion Injury Our abstract "Targeted mTOR Suppression Using a Novel Optoacoustic Imaging Strategy Improves Myocardial Ischemia/Repe…

The primary aim of our research is to advance the understanding of chronic liver diseases, including metabolic dysfunction-associated steatohepatitis (MASH), alcoholic liver disease (ASH), liver fibrosis/cirrhosis, and hepatocellular carcinoma (HCC). By leveraging advanced 'omics' technologies, mouse genetics, and sophisticated pathohistological analyses, we strive to uncover the fundamental mechanisms behind the onset and progression of these diseases. Ultimately, our goal is to translate these insights into innovative therapeutic strategies to improve patient outcomes.

The news link is where you will find information about new research, lab members, publications, and awards in the Liang Lab.

Radiology lab led by Dr. Paulo Eduardo de Aguiar Kuriki. Clinical AI, built for real-world radiology.

Skip to main content Publications New Publication in Advanced Functional Materials! Now published in Advanced Functional Materials, We have developed a new class of dithiolane-modified, protein-based biomaterial that combines unique functions for tissue engineering. Multi-Functional Gelatin-Dithiolan…

Contact us to get involved at Kohler Lab.

Skip to main content Investigator initiated clinical and translational research program in childhood sarcoma Beginning with an individual investigator award from the Cancer Prevention and Research Institute of Texas ( RP150164 ), Dr. Leavey developed a long-lasting collaboration with Dr. Ovidiu Daesc…

Meet the Kohler Lab current and alumni members.

Kohler research group at UT Southwestern is committed to developing and implementing new tools that are optimized for the study of glycosylated molecules. In particular, we invested significant effort in the development of photocrosslinking sugar analogs that can be metabolically incorporated into cellular glycoconjugates and used to covalently crosslink glycan-mediated interactions.